Mesa Biotech, Inc. – Trademark Portfolio
Entity Type: 03
Mesa Biotech, Inc. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 4 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include OSCAR, ACCULA, and MESABIOTECH. The owner is based in Carlsbad, CA.
5823 Newton Drive
Carlsbad, CA 92008-736
Showing of trademarks Trademarks
Trademark Classifications
Mesa Biotech, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Mesa Biotech, Inc. have?
Mesa Biotech, Inc. has 8 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 abandoned, 2 cancelled.
What trademark classes does Mesa Biotech, Inc. file in?
Mesa Biotech, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 1 (Chemicals), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Mesa Biotech, Inc.'s most well-known trademarks?
Mesa Biotech, Inc.'s registered trademark portfolio includes well-known marks such as OSCAR, ACCULA, and MESABIOTECH. These are among 5 currently registered trademarks in the portfolio.
What is Mesa Biotech, Inc.'s trademark registration success rate?
Mesa Biotech, Inc. has a 63% trademark registration rate, with 5 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.